Susceptibility to DNA Damage as a Molecular Mechanism for Non-Syndromic Cleft Lip and Palate

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Kobayashi, Gerson Shigeru ^a   Alvizi, Lucas ^a   Sunaga, Daniele Yumi ^a   Francis West, Philippa ^b   Kuta, Anna ^b   Almada, Bruno Vinícius Pimenta ^a   Ferreira, Simone Gomes ^a   de Andrade Lima, Leonardo Carmo ^a   Bueno, Daniela Franco ^a,c   Raposo Amaral, Cássio Eduardo ^c   Menck, Carlos Frederico ^a   Passos Bueno, Maria Rita ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SOBRAPAR   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; PROTEIN MSH2; RAD51 PROTEIN; TRANSCRIPTION FACTOR E2F1;

ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CHILD; CLEFT LIP PALATE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MORPHOGENESIS; MOUSE; MSH2 GENE; NONHUMAN; NONSYNDROMIC CLEFT LIP PALATE; PATHOGENESIS; PRIMORDIUM; RAD51 GENE; STEM CELL; TOOTH PULP; TRANSCRIPTOMICS; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; CELL CYCLE; CELLS, CULTURED; CHILD; CLEFT LIP; CLEFT PALATE; DENTAL PULP; DNA BREAKS, DOUBLE-STRANDED; DNA PRIMERS; DNA REPAIR; E2F1 TRANSCRIPTION FACTOR; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; IN SITU HYBRIDIZATION; MUTS HOMOLOG 2 PROTEIN; PROTEIN ARRAY ANALYSIS; RAD51 RECOMBINASE; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 84878920367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065677     Document Type: Article

References (88)

1. Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC, (2009) Cleft lip and palate. Lancet 374: 1773-1785.
2. Brito LA, Cruz LA, Rocha KM, Barbara LK, Silva CB, et al. (2011) Genetic contribution for non-syndromic cleft lip with or without cleft palate (NS CL/P) in different regions of Brazil and implications for association studies. Am J Med Genet A 155A: 1581-1587.
3. Birnbaum S, Ludwig KU, Reutter H, Herms S, Steffens M, et al. (2009) Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24. Nat Genet 41: 473-477.
4. Grant SF, Wang K, Zhang H, Glaberson W, Annaiah K, et al. (2009) A genome-wide association study identifies a locus for nonsyndromic cleft lip with or without cleft palate on 8q24. J Pediatr 155: 909-913.
5. Mangold E, Ludwig KU, Birnbaum S, Baluardo C, Ferrian M, et al. (2009) Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat Genet 42: 24-26.
6. Beaty TH, Murray JC, Marazita ML, Munger RG, Ruczinski I, et al. (2009) A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat Genet 42: 525-529.
7. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M, (2009) Mapping complex disease traits with global gene expression. Nat Rev Genet 10: 184-194.
8. Baroni T, Bellucci C, Lilli C, Pezzetti F, Carinci F, et al. (2010) Human cleft lip and palate fibroblasts and normal nicotine-treated fibroblasts show altered in vitro expressions of genes related to molecular signaling pathways and extracellular matrix metabolism. J Cell Physiol 222: 748-756.
9. Bueno DF, Sunaga DY, Kobayashi GS, Aguena M, Raposo-Amaral CE, et al. (2010) Human stem cell cultures from cleft lip/palate patients show enrichment of transcripts involved in extracellular matrix modeling by comparison to controls. Stem Cell Rev 7: 446-457.
10. Marinucci L, Balloni S, Bodo M, Carinci F, Pezzetti F, et al. (2009) Patterns of some extracellular matrix gene expression are similar in cells from cleft lip-palate patients and in human palatal fibroblasts exposed to diazepam in culture. Toxicology 257: 10-16.
11. Pezzetti F, Carinci F, Palmieri A, Vizzotto L, Moscheni C, et al. (2009) Diphenylhydantoin plays a role in gene expression related to cytoskeleton and protein adhesion in human normal palate fibroblasts. Pathology 41: 261-268.
12. Jiang R, Bush JO, Lidral AC, (2006) Development of the upper lip: morphogenetic and molecular mechanisms. Dev Dyn 235: 1152-1166.
13. Greene RM, Pisano MM, (2010) Palate morphogenesis: Current understanding and future directions. Birth Defects Res C Embryo Today 90: 133-154.
14. Yu W, Serrano M, Miguel SS, Ruest LB, Svoboda KK, (2009) Cleft lip and palate genetics and application in early embryological development. Indian J Plast Surg 42Suppl: S35-50.
15. Zhu JL, Basso O, Hasle H, Winther JF, Olsen JH, et al. (2002) Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark. Br J Cancer 87: 524-528.
16. Taioli E, Ragin C, Robertson L, Linkov F, Thurman NE, et al. (2010) Cleft lip and palate in family members of cancer survivors. Cancer Invest 28: 958-962.
17. Bille C, Winther JF, Bautz A, Murray JC, Olsen J, et al. (2005) Cancer risk in persons with oral cleft-a population-based study of 8,093 cases. Am J Epidemiol 161: 1047-1055.
18. Vieira AR, Khaliq S, Lace B, (2012) Risk of cancer in relatives of children born with isolated cleft lip and palate. Am J Med Genet A 158A: 1503-1504.
19. Rinne T, Brunner HG, van Bokhoven H, (2007) p63-associated disorders. Cell Cycle 6: 262-268.
20. Restivo G, Nguyen BC, Dziunycz P, Ristorcelli E, Ryan RJ, et al. (2011) IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J 30: 4571-4585.
21. Letra A, Bjork B, Cooper ME, Szabo-Rogers H, Deleyiannis FW, et al. (2012) Association of AXIN2 with non-syndromic oral clefts in multiple populations. J Dent Res 91: 473-478.
22. Krenzlin H, Demuth I, Salewsky B, Wessendorf P, Weidele K, et al. (2012) DNA damage in Nijmegen Breakage Syndrome cells leads to PARP hyperactivation and increased oxidative stress. PLoS Genet 8: e1002557.
23. Ferone G, Thomason HA, Antonini D, De Rosa L, Hu B, et al. (2012) Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome. EMBO Mol Med 4: 192-205.
24. Vogelaar IP, Figueiredo J, van Rooij IA, Simoes-Correia J, van der Post RS, et al. (2013) Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts. Hum Mol Genet 22: 919-926.
25. Cordero DR, Brugmann S, Chu Y, Bajpai R, Jame M, et al. (2011) Cranial neural crest cells on the move: their roles in craniofacial development. Am J Med Genet A 155A: 270-279.
26. Komada M, (2012) Sonic hedgehog signaling coordinates the proliferation and differentiation of neural stem/progenitor cells by regulating cell cycle kinetics during development of the neocortex. Congenit Anom (Kyoto) 52: 72-77.
27. Janebodin K, Horst OV, Ieronimakis N, Balasundaram G, Reesukumal K, et al. (2011) Isolation and characterization of neural crest-derived stem cells from dental pulp of neonatal mice. PLoS One 6: e27526.
28. Yarden RI, Papa MZ, (2006) BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions. Mol Cancer Ther 5: 1396-1404.
29. Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJ, et al. (2009) Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci 108: 4-18.
30. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC, (2004) Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 6: 289-300.
31. Weyemi U, Dupuy C, (2012) The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses. Mutat Res 751: 77-81.
32. Yu H, Liu Z, Zhou H, Dai W, Chen S, et al. (2012) JAK-STAT pathway modulates the roles of iNOS and COX-2 in the cytoprotection of early phase of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress. Neurosci Lett 529: 166-171.
33. Li H, Sekine M, Seng S, Avraham S, Avraham HK, (2009) BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses. PLoS One 4: e7091.
34. Uno S, Masai H, (2011) Efficient expression and purification of human replication fork-stabilizing factor, Claspin, from mammalian cells: DNA-binding activity and novel protein interactions. Genes Cells 16: 842-856.
35. Saha T, Rih JK, Roy R, Ballal R, Rosen EM, (2010) Transcriptional regulation of the base excision repair pathway by BRCA1. J Biol Chem 285: 19092-19105.
36. Lydeard JR, Lipkin-Moore Z, Sheu YJ, Stillman B, Burgers PM, et al. (2010) Break-induced replication requires all essential DNA replication factors except those specific for pre-RC assembly. Genes Dev 24: 1133-1144.
37. Maiorano D, Lutzmann M, Mechali M, (2006) MCM proteins and DNA replication. Curr Opin Cell Biol 18: 130-136.
38. Linger RJ, Kruk PA, (2010) BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications. FEBS J 277: 3086-3096.
39. Seifert M, Reichrath J, (2006) The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer. J Mol Histol 37: 301-307.
40. Yata K, Esashi F, (2009) Dual role of CDKs in DNA repair: to be, or not to be. DNA Repair (Amst) 8: 6-18.
41. Biswas AK, Johnson DG, (2011) Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer Res 72: 13-17.
42. Iaquinta PJ, Lees JA, (2007) Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 19: 649-657.
43. Kusek JC, Greene RM, Nugent P, Pisano MM, (2000) Expression of the E2F family of transcription factors during murine development. Int J Dev Biol 44: 267-277.
44. Dixon K, Kopras E, (2004) Genetic alterations and DNA repair in human carcinogenesis. Semin Cancer Biol 14: 441-448.
45. Rosen EM, Fan S, Ma Y, (2006) BRCA1 regulation of transcription. Cancer Lett 236: 175-185.
46. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT, (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9: 444-450.
47. Lee WY, Jin YT, Chang TW, Lin PW, Su IJ, (1999) Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters. Histopathology 34: 106-112.
48. Mueller CR, Roskelley CD, (2003) Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res 5: 45-52.
49. Calin G, Herlea V, Barbanti-Brodano G, Negrini M, (1998) The coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumors. Cancer Res 58: 3777-3781.
50. Borlado LR, Mendez J, (2008) CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. Carcinogenesis 29: 237-243.
51. Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, et al. (2010) RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat 125: 827-835.
52. Helleday T, Lo J, van Gent DC, Engelward BP, (2007) DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst) 6: 923-935.
53. Llorente B, Smith CE, Symington LS, (2008) Break-induced replication: what is it and what is it for? Cell Cycle 7: 859-864.
54. Pardo B, Gomez-Gonzalez B, Aguilera A, (2009) DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship. Cell Mol Life Sci 66: 1039-1056.
55. Langerak P, Russell P, (2011) Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repair. Philos Trans R Soc Lond B Biol Sci 366: 3562-3571.
56. Mao Z, Bozzella M, Seluanov A, Gorbunova V, (2008) Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst) 7: 1765-1771.
57. Letavayova L, Markova E, Hermanska K, Vlckova V, Vlasakova D, et al. (2006) Relative contribution of homologous recombination and non-homologous end-joining to DNA double-strand break repair after oxidative stress in Saccharomyces cerevisiae. DNA Repair (Amst) 5: 602-610.
58. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14: 927-939.
59. Bahado-Singh RO, Schenone M, Cordoba M, Shieh WS, Maulik D, et al. (2011) Male gender significantly increases risk of oxidative stress related congenital anomalies in the non-diabetic population. J Matern Fetal Neonatal Med 24: 687-691.
60. Nulman I, Scolnik D, Chitayat D, Farkas LD, Koren G, (1997) Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet 68: 18-24.
61. Winn LM, Kim PM, Nickoloff JA, (2003) Oxidative stress-induced homologous recombination as a novel mechanism for phenytoin-initiated toxicity. J Pharmacol Exp Ther 306: 523-527.
62. Alsdorf R, Wyszynski DF, (2005) Teratogenicity of sodium valproate. Expert Opin Drug Saf 4: 345-353.
63. DeRoo LA, Wilcox AJ, Drevon CA, Lie RT, (2008) First-trimester maternal alcohol consumption and the risk of infant oral clefts in Norway: a population-based case-control study. Am J Epidemiol 168: 638-646.
64. Leite IC, Koifman S, (2009) Oral clefts, consanguinity, parental tobacco and alcohol use: a case-control study in Rio de Janeiro, Brazil. Braz Oral Res 23: 31-37.
65. Sha K, Winn LM, (2010) Characterization of valproic acid-initiated homologous recombination. Birth Defects Res B Dev Reprod Toxicol 89: 124-132.
66. Tung EW, Winn LM, (2011) Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects. Mol Pharmacol 80: 979-987.
67. Park SC, Lim JY, Jeen YT, Keum B, Seo YS, et al. (2012) Ethanol-induced DNA damage and repair-related molecules in human intestinal epithelial Caco-2 cells. Mol Med Report 5: 1027-1032.
68. Kachhap SK, Rosmus N, Collis SJ, Kortenhorst MS, Wissing MD, et al. (2010) Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor. PLoS One 5: e11208.
69. Wehby GL, Murray JC, (2010) Folic acid and orofacial clefts: a review of the evidence. Oral Dis 16: 11-19.
70. Joshi R, Adhikari S, Patro BS, Chattopadhyay S, Mukherjee T, (2001) Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Radic Biol Med 30: 1390-1399.
71. Gliszczynska-Swiglo A, Muzolf M, (2007) pH-Dependent radical scavenging activity of folates. J Agric Food Chem 55: 8237-8242.
72. Bliek BJ, Steegers-Theunissen RP, Blok LJ, Santegoets LA, Lindemans J, et al. (2008) Genome-wide pathway analysis of folate-responsive genes to unravel the pathogenesis of orofacial clefting in man. Birth Defects Res A Clin Mol Teratol 82: 627-635.
73. Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, et al. (2002) Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet 32: 285-289.
74. Washbourne BJ, Cox TC, (2006) Expression profiles of cIRF6, cLHX6 and cLHX7 in the facial primordia suggest specific roles during primary palatogenesis. BMC Dev Biol 6: 18.
75. Rocha CR, Lerner LK, Okamoto OK, Marchetto MC, Menck CF (2012) The role of DNA repair in the pluripotency and differentiation of human stem cells. Mutat Res.
76. Feng W, Leach SM, Tipney H, Phang T, Geraci M, et al. (2009) Spatial and temporal analysis of gene expression during growth and fusion of the mouse facial prominences. PLoS One 4: e8066.
77. Albino D, Brizzolara A, Moretti S, Falugi C, Mirisola V, et al. (2011) Gene expression profiling identifies eleven DNA repair genes down-regulated during mouse neural crest cell migration. Int J Dev Biol 55: 65-72.
78. de Mendonca Costa A, Bueno DF, Martins MT, Kerkis I, Kerkis A, et al. (2008) Reconstruction of large cranial defects in nonimmunosuppressed experimental design with human dental pulp stem cells. J Craniofac Surg 19: 204-210.
79. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
80. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
81. Breitling R, Armengaud P, Amtmann A, Herzyk P, (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92.
82. Raj A, Rifkin SA, Andersen E, van Oudenaarden A, (2010) Variability in gene expression underlies incomplete penetrance. Nature 463: 913-918.
83. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
84. Severin J, Waterhouse AM, Kawaji H, Lassmann T, van Nimwegen E, et al. (2009) FANTOM4 EdgeExpressDB: an integrated database of promoters, genes, microRNAs, expression dynamics and regulatory interactions. Genome Biol 10: R39.
85. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
86. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
87. Huang X, Darzynkiewicz Z, (2006) Cytometric assessment of histone H2AX phosphorylation: a reporter of DNA damage. Methods Mol Biol 314: 73-80.
88. Dastjerdi A, Robson L, Walker R, Hadley J, Zhang Z, et al. (2007) Tbx1 regulation of myogenic differentiation in the limb and cranial mesoderm. Dev Dyn 236: 353-363.